These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27086975)

  • 1. Oxidative injury in multiple sclerosis cerebellar grey matter.
    Kemp K; Redondo J; Hares K; Rice C; Scolding N; Wilkins A
    Brain Res; 2016 Jul; 1642():452-460. PubMed ID: 27086975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased microglial catalase activity in multiple sclerosis grey matter.
    Gray E; Kemp K; Hares K; Redondo J; Rice C; Scolding N; Wilkins A
    Brain Res; 2014 Apr; 1559():55-64. PubMed ID: 24602691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.
    van Wageningen TA; Vlaar E; Kooij G; Jongenelen CAM; Geurts JJG; van Dam AM
    Acta Neuropathol Commun; 2019 Dec; 7(1):206. PubMed ID: 31829283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
    Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
    Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes.
    van der Poel M; Ulas T; Mizee MR; Hsiao CC; Miedema SSM; Adelia ; Schuurman KG; Helder B; Tas SW; Schultze JL; Hamann J; Huitinga I
    Nat Commun; 2019 Mar; 10(1):1139. PubMed ID: 30867424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray and white matter are both affected in classical galactosemia: An explorative study on the association between neuroimaging and clinical outcome.
    Welsink-Karssies MM; Schrantee A; Caan MWA; Hollak CEM; Janssen MCH; Oussoren E; de Vries MC; Roosendaal SD; Engelen M; Bosch AM
    Mol Genet Metab; 2020 Dec; 131(4):370-379. PubMed ID: 33199205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis.
    Prins M; Eriksson C; Wierinckx A; Bol JG; Binnekade R; Tilders FJ; Van Dam AM
    PLoS One; 2013; 8(12):e83835. PubMed ID: 24376764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space.
    Howell OW; Schulz-Trieglaff EK; Carassiti D; Gentleman SM; Nicholas R; Roncaroli F; Reynolds R
    Neuropathol Appl Neurobiol; 2015 Oct; 41(6):798-813. PubMed ID: 25421634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological correlates of cerebellar volumes in multiple sclerosis: an MRI volumetric analysis study.
    Iliadou P; Bakirtzis C; Ioannidis P; Possin K; Zygouris S; Sintila SA; Grigoriadis N; Aretouli E
    J Integr Neurosci; 2022 Jan; 21(1):13. PubMed ID: 35164449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis.
    Chomyk A; Kucinski R; Kim J; Christie E; Cyncynatus K; Gossman Z; Chen Z; Richardson B; Cameron M; Turner T; Dutta R; Trapp B
    Ann Neurol; 2024 May; 95(5):907-916. PubMed ID: 38345145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
    Gray E; Rice C; Hares K; Redondo J; Kemp K; Williams M; Brown A; Scolding N; Wilkins A
    Mult Scler; 2014 May; 20(6):651-9. PubMed ID: 24067896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
    Haider L; Simeonidou C; Steinberger G; Hametner S; Grigoriadis N; Deretzi G; Kovacs GG; Kutzelnigg A; Lassmann H; Frischer JM
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1386-95. PubMed ID: 24899728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis.
    Gorter RP; Nutma E; Jahrei MC; de Jonge JC; Quinlan RA; van der Valk P; van Noort JM; Baron W; Amor S
    Clin Exp Immunol; 2018 Nov; 194(2):137-152. PubMed ID: 30014472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningeal inflammation and cortical demyelination in acute multiple sclerosis.
    Bevan RJ; Evans R; Griffiths L; Watkins LM; Rees MI; Magliozzi R; Allen I; McDonnell G; Kee R; Naughton M; Fitzgerald DC; Reynolds R; Neal JW; Howell OW
    Ann Neurol; 2018 Dec; 84(6):829-842. PubMed ID: 30362156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viscoelastic properties of white and gray matter-derived microglia differentiate upon treatment with lipopolysaccharide but not upon treatment with myelin.
    van Wageningen TA; Antonovaite N; Paardekam E; Brevé JJP; Iannuzzi D; van Dam AM
    J Neuroinflammation; 2021 Mar; 18(1):83. PubMed ID: 33781276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients.
    Prins M; Dutta R; Baselmans B; Brevé JJ; Bol JG; Deckard SA; van der Valk P; Amor S; Trapp BD; de Vries HE; Drukarch B; van Dam AM
    Acta Neuropathol Commun; 2014 Aug; 2():98. PubMed ID: 25149422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    Johnson TW; Wu Y; Nathoo N; Rogers JA; Wee Yong V; Dunn JF
    PLoS One; 2016; 11(12):e0167196. PubMed ID: 27907119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
    Nyamoya S; Leopold P; Becker B; Beyer C; Hustadt F; Schmitz C; Michel A; Kipp M
    Mol Neurobiol; 2019 Feb; 56(2):1109-1123. PubMed ID: 29873041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic correlates of the magnetization transfer ratio in multiple sclerosis.
    Moccia M; van de Pavert S; Eshaghi A; Haider L; Pichat J; Yiannakas M; Ourselin S; Wang Y; Wheeler-Kingshott C; Thompson A; Barkhof F; Ciccarelli O
    Neurology; 2020 Dec; 95(22):e2965-e2976. PubMed ID: 32938787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histopathology of grey matter demyelination in multiple sclerosis.
    Bø L
    Acta Neurol Scand Suppl; 2009; (189):51-7. PubMed ID: 19566500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.